Tumor Somatic Mutation Rate Predicts Response to Anti-PD-1 Therapy in RCC: A Pilot Study

(2016) Tumor Somatic Mutation Rate Predicts Response to Anti-PD-1 Therapy in RCC: A Pilot Study. Modern Pathology. 265a-265a. ISSN 0893-3952

Full text not available from this repository.

Item Type: Article
Page Range: 265a-265a
Journal or Publication Title: Modern Pathology
Journal Index: ISI
Volume: 29
ISSN: 0893-3952
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/2831

Actions (login required)

View Item View Item